Protagenic Therapeutics Inc (PTIX)
1.35
-0.09
(-6.25%)
USD |
NASDAQ |
May 21, 16:00
1.35
0.00 (0.00%)
After-Hours: 16:30
Protagenic Therapeutics Net Income (Quarterly): -1.676M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -1.676M |
| September 30, 2023 | -1.397M |
| June 30, 2023 | -1.210M |
| March 31, 2023 | -0.7181M |
| December 31, 2022 | -0.6014M |
| September 30, 2022 | -0.9253M |
| June 30, 2022 | -0.6667M |
| March 31, 2022 | -1.362M |
| December 31, 2021 | -0.8904M |
| September 30, 2021 | -0.8783M |
| June 30, 2021 | -1.548M |
| March 31, 2021 | -1.206M |
| December 31, 2020 | -0.5237M |
| September 30, 2020 | -1.046M |
| June 30, 2020 | -0.5674M |
| March 31, 2020 | -0.4986M |
| December 31, 2019 | -0.7499M |
| September 30, 2019 | -0.1233M |
| June 30, 2019 | -0.2785M |
| March 31, 2019 | -0.5992M |
| December 31, 2018 | -0.7897M |
| September 30, 2018 | -0.4975M |
| June 30, 2018 | -0.6714M |
| March 31, 2018 | -0.5982M |
| December 31, 2017 | -0.6961M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.4546M |
| June 30, 2017 | -0.4511M |
| March 31, 2017 | -0.6579M |
| December 31, 2016 | -0.5561M |
| September 30, 2016 | -0.4555M |
| June 30, 2016 | -0.5245M |
| March 31, 2016 | -0.7398M |
| December 31, 2015 | -0.158M |
| September 30, 2015 | -0.131M |
| June 30, 2015 | -0.112M |
| March 31, 2015 | -0.119M |
| December 31, 2014 | -0.133M |
| September 30, 2014 | -0.112M |
| June 30, 2014 | -0.096M |
| March 31, 2014 | -0.37M |
| December 31, 2013 | -0.22M |
| September 30, 2013 | -0.394M |
| September 30, 2011 | -4.522M |
| June 30, 2011 | -6.153M |
| March 31, 2011 | -3.514M |
| December 31, 2010 | -8.165M |
| September 30, 2010 | -3.636M |
| June 30, 2010 | -4.492M |
| March 31, 2010 | -3.435M |
| December 31, 2009 | -23.95M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-1.676M
Minimum
Dec 2023
-0.1233M
Maximum
Sep 2019
-0.8877M
Average
-0.8783M
Median
Sep 2021
Net Income (Quarterly) Benchmarks
| Ekso Bionics Holdings Inc | -3.429M |
| Eyenovia Inc | -10.92M |
| Palisade Bio Inc | -3.527M |
| NovaBay Pharmaceuticals Inc | -3.214M |
| Palatin Technologies Inc | -8.436M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 1.212M |
| EPS Diluted (Quarterly) | -0.38 |
| Enterprise Value | 2.330M |
| Earnings Yield | -85.19% |